A Mouse Model for Vitiligo

Tucker RW, 1977, Cancer Res, 37, 1571 Todaro GJ, 1965, J Cell Comp Physiol, 6, 325, 10.1002/jcp.1030660310 Aaronson SA, 1968, Science, 162, 1024, 10.1126/science.162.3857.1024 Pollack RE, Green H, Todaro GJ: Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing activity. Proc Natl Acad Sci USA 60:126-133, 1968 Pollack RE, 1969, Cancer Res, 29, 1770 10.1084/jem.138.5.1056 Laug WE, 1975, J Natl Cancer Inst, 54, 173, 10.1093/jnci/54.1.173 Pearlstein E., 1976, Cancer Res, 36, 1475 Montesano R., 1977, J Natl Cancer Inst, 59, 1651, 10.1093/jnci/59.6.1651 Barret JC, 1979, Cancer Res, 39, 1504 San RHC, 1979, Cancer Res, 39, 1026 Canary PK, 1978, J Cell Biol, 79, 397a 10.1083/jcb.82.1.1 Hynes RO, 1976, Biochim Biophys Acta, 485, 73 10.1016/0304-419X(76)90014-7 Pollack R, Osborn M, Weber K: Patterns of organization of actin and myosin in normal and transformed cultured cells. Proc Natl Acad Sci USA 72:994-998, 1975 Folkman J., 1978, Nature, 273, 345, 10.1038/273345a0 Paul D, Lipton A, Klinger I: Serum factor requirements of normal and simian virus 40-transformed 3T3 mouse fibroblasts. Proc Natl Acad Sci USA 68:645-648. 1971 10.1016/0042-6822(71)90267-4 Holley RW, Kiernan JW: Control of the initiation of DNA synthesis in 3T3 cells: serum factors. Proc Natl Acad Sci USA 71:2908-2911, 1974 Dulbecco R., 1970, Nature, 227, 802, 10.1038/227802a0 10.1016/0042-6822(64)90301-0 10.1016/0092-8674(74)90050-6 Shin S, Freedman VH, Risser R, Pollack R: Tumorigenicity of virustransformed cells in nude mice is correlated specifically with anchorage independent growthin vivo. Proc Natl Acad Sci USA 11:4435-4439, 1975 Jones PA, 1976, Cancer Res, 36, 2863 Ruben RL, 1978, J Natl Cancer Inst, 61, 993 Marshall CJ, 1977, J Natl Cancer Inst, 58, 1743, 10.1093/jnci/58.6.1743 Stanbridge EJ, Wilkinson T: Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control. Proc Natl Acad Sci USA 75:1466-1469, 1978 Tucker RW, 1977, Cancer Res, 37, 1571 Colburn NH, 1978, Cancer Res, 38, 624 Lipkin G, Knecht M: A diffusible factor restoring contact inhibition of growth to malignant melanocytes. Proc Natl Acad Sci USA 71:849-853, 1974 Lipkin G: Altered malignancy and increased contact inhibition of amelanotic melanoma cell line after pigment transformation by nucleic acids from benign blue nevi. Proc Am Assoc Cancer Res 12:26, 1971 Lipkin G., 1971, J Invest Dermatol, 57, 49, 10.1111/1523-1747.ep12292072 Lipkin G: Use of mammalian nucleic acids in studies on transformation of tumor cells. Methods in Cancer Research, vol 8. Edited by H Busch. New York, Academic Press, 1973, pp 339-384 Lipkin G., 1976, Exp Cell Res, 102, 341, 10.1016/0014-4827(76)90049-5 Lipkin G., 1978, Cancer Res, 38, 635 Lipkin G., 1985, Differentiation, 30, 35, 10.1111/j.1432-0436.1985.tb00510.x Nabi ZF, 1986, Cancer Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936-2940, 1980 10.1016/0092-8674(78)90008-9 Dion LD, 1977, J Natl Cancer Inst, 58, 795, 10.1093/jnci/58.3.795 Dion LD, 1978, Exp Cell Res, 117, 15, 10.1016/0014-4827(78)90422-6 Patt LM, 1978, Nature, 273, 379, 10.1038/273379a0 Mannino RJ, 1978, Science, 201, 824, 10.1126/science.210502 Lipkin G., 1978, Ann NY Acad Sci, 312, 382, 10.1111/j.1749-6632.1978.tb16815.x